Notch Therapeutics
Notch Therapeutics, founded in 2018 and based in Vancouver, BC, is pioneering the development of innovative T cell therapies derived from induced pluripotent stem cells (iPSCs). Their flagship product, the UNiT Cell, offers a cost-effective and accessible off-the-shelf solution aimed at addressing key challenges in adoptive cell therapy.
By focusing on scalable manufacturing and the creation of uniform, drug-like T cell therapies, Notch Therapeutics is positioned to enhance patient access to cellular immunotherapies. Their approach emphasizes persistent and potent therapies that can be delivered at the time of diagnosis, ultimately aiming to improve treatment outcomes for a broader range of patients.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.